PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 70 filers reported holding PRELUDE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,625 | -90.6% | 526 | -86.3% | 0.00% | – |
| Q2 2023 | $17,285 | -95.7% | 3,841 | -94.6% | 0.00% | – |
| Q1 2023 | $403,372 | +11.2% | 70,767 | +17.8% | 0.00% | – |
| Q4 2022 | $362,835 | +547.9% | 60,072 | +604.1% | 0.00% | – |
| Q3 2022 | $56,000 | +1300.0% | 8,532 | +914.5% | 0.00% | – |
| Q2 2022 | $4,000 | -66.7% | 841 | -51.1% | 0.00% | – |
| Q1 2022 | $12,000 | -76.5% | 1,719 | -57.8% | 0.00% | – |
| Q4 2021 | $51,000 | -93.3% | 4,078 | -83.2% | 0.00% | – |
| Q3 2021 | $758,000 | -65.0% | 24,268 | -67.9% | 0.00% | -100.0% |
| Q2 2021 | $2,165,000 | -17.6% | 75,623 | +24.8% | 0.00% | -50.0% |
| Q1 2021 | $2,626,000 | +2017.7% | 60,597 | +3400.7% | 0.00% | – |
| Q4 2020 | $124,000 | – | 1,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |